EYLEA - 61755-005-02 - (aflibercept)

Alphabetical Index


Drug Information of EYLEA

Product NDC: 61755-005
Proprietary Name: EYLEA
Non Proprietary Name: aflibercept
Active Ingredient(s): 40    mg/mL & nbsp;   aflibercept
Administration Route(s): INTRAVITREAL
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of EYLEA

Product NDC: 61755-005
Labeler Name: Regeneron Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125387
Marketing Category: BLA
Start Marketing Date: 20111121

Package Information of EYLEA

Package NDC: 61755-005-02
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) > .05 mL in 1 VIAL, SINGLE-USE

NDC Information of EYLEA

NDC Code 61755-005-02
Proprietary Name EYLEA
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) > .05 mL in 1 VIAL, SINGLE-USE
Product NDC 61755-005
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name aflibercept
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVITREAL
Start Marketing Date 20111121
Marketing Category Name BLA
Labeler Name Regeneron Pharmaceuticals, Inc.
Substance Name AFLIBERCEPT
Strength Number 40
Strength Unit mg/mL
Pharmaceutical Classes

Complete Information of EYLEA


General Information